Challenges and shifting paradigms in clinical trials in oncology: the case for immunological and targeted therapies

The advent of immunotherapy has undoubtedly changed the current standard for cancer treatment. Immunotherapy offers the possibility of achieving excellent results—a new alternative for patients with advanced-stage or relapsed disease. Nowadays, the progress made in tumour biology has led to multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotelo-Rodríguez, Diana Carolina, Ruíz-Patiño, Alejandro, Ricaurte, Luisa, Arrieta, Oscar, Zatarain-Barrón, Zyanya Lucia, Cardona, Andrés F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695130/
https://www.ncbi.nlm.nih.gov/pubmed/31552109
http://dx.doi.org/10.3332/ecancer.2019.936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695130/
https://www.ncbi.nlm.nih.gov/pubmed/31552109
http://dx.doi.org/10.3332/ecancer.2019.936

Ejemplares similares